News Release

01/13/2023: Information

Resuming normal office operations

01/11/2023: Information

2023 New Year Greeting

01/04/2023: Information

FAQ for Our Disclosure on December 27, 2022, “GNI Group and Catalyst Biosciences Signed Agreements to Advance Liver Fibrosis Drug Development”